mRNA-1982: Dose 1 for Lyme Disease
This trial looks at how safe and effective two vaccines are for Lyme disease in healthy adults.
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Does this experiment currently accept individuals who are more than half a century old?
"This clinical trial is seeking patients aged between 18 and 70 to partake in the study. Separately, there are 4 distinct studies for minors below 18 years of age, as well as 8 specialised trials for seniors over 65."
At which locations is this experiment presently being conducted?
"As of now, 20 sites in Connecticut, Florida and other places are running this clinical trial. To reduce the amount of travelling you'll have to do if you decide to take part, make sure to pick a location close by."
Is this experiment enrolling subjects at this moment?
"Affirmative. According to clinicaltrials.gov, this clinical trial is currently inviting candidates for participation. It was first announced on July 26th 2023 and recently updated the same day; 800 patients are needed from a total of twenty medical centres."
How many individuals are presently enrolled in this clinical research?
"To properly conduct the trial, 800 eligible patients must be recruited. ModernaTX Inc., will preside over this experiment and its operations in Stamford Therapeutics Consortium (Stamford, Florida) as well as Chase Medical Research LLC (Waterbury, Georgia)."